Clonal hematopoiesis in solid tumors: mutant hematopoietic cells as a tumor-microenvironment component across source, lineage and treatment
Clonal hematopoiesis (CH) introduces a hematopoietic component into the molecular and immune landscape of solid tumors. Its interpretation depends on whether a variant is measured in blood, plasma or tumor tissue, which cells carry it, and when sampling occurs relative to treatment.